Literature DB >> 16546475

C-reactive protein genotype affects exercise training-induced changes in insulin sensitivity.

Thomas O Obisesan1, Christiaan Leeuwenburgh, Robert E Ferrell, Dana A Phares, Jennifer A McKenzie, Steven J Prior, James M Hagberg.   

Abstract

An etiologic role for chronic inflammation in the development of insulin resistance has been hypothesized. We determined whether the -732A/G and +219G/A C-reactive protein (CRP) gene variants affect insulin and glucose measures and whether these variants affect training-related changes in insulin sensitivity and glucose measures. Men and women 50 to 75 years old (n = 61) underwent baseline testing that included glucose tolerance, maximal oxygen consumption, body composition, CRP levels, and genotyping assessments. Tests were repeated after 24 weeks of aerobic exercise training. In bivariate analyses, CRP -732A/G G allele carriers had significantly lower baseline postprandial plasma glucose and after-training CRP levels. After exercise training, the -732A/G G allele carriers had approximately 28% increase in insulin sensitivity index (ISI) and approximately 26% reduction in insulin area under the curve (AUC), compared with the approximately 7% increase in ISI and approximately 15% reduction in insulin AUC in the A allele homozygotes (P = .03). The significant enhancement of ISI in -732A/G G allele carriers remained evident in analyses limited to those with normal glucose tolerance. Multivariate analyses adjusted for demographic and biologic variables confirmed the significant enhancement of training-induced improvement in ISI by the CRP gene variant. In addition, the CRP -732A/G and +219G/A haplotype significantly associated with training-induced improvements in ISI and insulin AUC in separate multivariate models. In conclusion, the CRP -732A/G variant modulates exercise training-related improvements in ISI and glucose AUC, and the haplotype of the CRP -732A/G and +219G/A variants significantly affected training-induced changes in ISI and insulin AUC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546475      PMCID: PMC2643021          DOI: 10.1016/j.metabol.2005.10.006

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  35 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

2.  Haplotype tagging for the identification of common disease genes.

Authors:  G C Johnson; L Esposito; B J Barratt; A N Smith; J Heward; G Di Genova; H Ueda; H J Cordell; I A Eaves; F Dudbridge; R C Twells; F Payne; W Hughes; S Nutland; H Stevens; P Carr; E Tuomilehto-Wolf; J Tuomilehto; S C Gough; D G Clayton; J A Todd
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

3.  Impact of moderate aerobic exercise training on insulin sensitivity in type 2 diabetic men treated with oral hypoglycemic agents: is insulin sensitivity enhanced only in non-obese subjects?

Authors:  Laszlo Bense
Journal:  Med Sci Monit       Date:  2002-06

Review 4.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Authors:  Paul M Ridker
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

5.  Dietary guidelines for healthy American adults. A statement for physicians and health professionals by the Nutrition Committee, American Heart Association.

Authors: 
Journal:  Circulation       Date:  1988-03       Impact factor: 29.690

6.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

7.  A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians.

Authors:  Johanna K Wolford; Jonathan D Gruber; Victoria M Ossowski; Barbora Vozarova; P Antonio Tataranni; Clifton Bogardus; Robert L Hanson
Journal:  Mol Genet Metab       Date:  2003-02       Impact factor: 4.797

8.  The effect of endurance exercise training on plasma lipoprotein AI and lipoprotein AI:AII concentrations in sedentary adults.

Authors:  Kenneth R Wilund; Perry L Colvin; Dana Phares; Andrew P Goldberg; James M Hagberg
Journal:  Metabolism       Date:  2002-08       Impact factor: 8.694

9.  C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

Authors:  Barbara Thorand; Hannelore Löwel; Andrea Schneider; Hubert Kolb; Christa Meisinger; Margit Fröhlich; Wolfgang Koenig
Journal:  Arch Intern Med       Date:  2003-01-13

10.  Elevated concentrations of C-reactive protein in subjects with type 2 diabetes mellitus are moderately influenced by glycemic control.

Authors:  M Rodríguez-Morán; F Guerrero-Romero
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

View more
  5 in total

1.  AKT1 G205T genotype influences obesity-related metabolic phenotypes and their responses to aerobic exercise training in older Caucasians.

Authors:  Jennifer A McKenzie; Sarah Witkowski; Andrew T Ludlow; Stephen M Roth; James M Hagberg
Journal:  Exp Physiol       Date:  2010-11-19       Impact factor: 2.969

2.  The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk.

Authors:  Wanqing Wen; Qiuyin Cai; Yong-Bing Xiang; Wang-Hong Xu; Zhi Xian Ruan; Jiarong Cheng; Wei Zheng; Xiao-Ou Shu
Journal:  Cancer       Date:  2008-06       Impact factor: 6.860

3.  Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention.

Authors:  Alaa Badawi; Amira Klip; Pierre Haddad; David Ec Cole; Bibiana Garcia Bailo; Ahmed El-Sohemy; Mohamed Karmali
Journal:  Diabetes Metab Syndr Obes       Date:  2010-05-26       Impact factor: 3.168

4.  Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes.

Authors:  Paul Arora; Bibiana Garcia-Bailo; Zari Dastani; Darren Brenner; Andre Villegas; Suneil Malik; Timothy D Spector; Brent Richards; Ahmed El-Sohemy; Mohamed Karmali; Alaa Badawi
Journal:  BMC Med Genet       Date:  2011-07-14       Impact factor: 2.103

5.  Neuroprotection and neurodegeneration in Alzheimer's disease: role of cardiovascular disease risk factors, implications for dementia rates, and prevention with aerobic exercise in african americans.

Authors:  Thomas O Obisesan; Richard F Gillum; Stephanie Johnson; Nisser Umar; Deborah Williams; Vernon Bond; John Kwagyan
Journal:  Int J Alzheimers Dis       Date:  2012-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.